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SResults: Access site cross over was needed in 1 patient (0.002%), and con-
version from sheathless guiding catheter to conventional guiding catheter in 1 patient
(0.002%). Acute procedural success rate was 95. 9%. The median duration of
the procedures was 50min (IQR 41-65). The median time of ﬂuoroscopy was
16.5min(IQR 12.7-23.6). The median contrast media use was 136ml (IQR 110-160).
Guiding catheter-induced coronary artery dissection occurred in 1 patient.
Conclusions: Routine use of the Sheathless guide catheter for TRA in PPCI
for STEMI is feasible with a low crossover rate and a high rate of procedural
success.
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Background: Up to our knowledge, there's no data investigating the three different
approaches (Transbrachial (TBA), Transradial (TRA) and Transfemoral (TFA) for
PCI .Coping with our daily needs for diversity of tools and approaches we explore our
extensive experiences with the different PCI accesses.
Methods: This retrospective observational,single center trial investigated 4955 CAD
patients underwent coronary revascularization through one of the studied approaches
between April 2006 to June 2012. After application of inclusion and exclusion
criteria.A total of 1102(22.2%),2797(56.4%)and,1054(21.2%)Patients were distrib-
uted through(TBA),TRA)and(TFA)accesses respectively.All patients were retrospec-
tively evaluated regards the predeﬁned primary safety endpoint(In hospital Cardiac
death,MI,stroke,major access site hematoma and/or bleeding)and efﬁcacy endpoints
(Access and procedure success/time,contrast volume,cross over rate and access site
complications.
Results: Over the 7 year study period,our results showed that both TBA and TRA
associated with higher procedural success compared with TFA(P¼0.0001)with no
signiﬁcant difference in access success and time.Both TBA and TRA groups have
shorter ﬂuoroscopy time(P¼0.0001).Regards the safety endpoints, our results
showed that TFA patients have higher rate of MACE and In–Hospital cardiac death
compared with TRA patients(p¼0.008 and 0.01 for MACE and cardiac death
respectively).Such difference is not encountered between TBA and either TRA or
TFA groups,however there was no signiﬁcant difference in MI,stroke,emergency
CABG.TFA group has signiﬁcantly higher incidence of major access site hematoma
(p¼0.0001).Both TBA and TFA groups have higher proportions of access site
pseudoaneurysm(P¼0.001).Primary Safety and efﬁcacy Endpoints between TBA,TRA and,TFA.
TBA (1102) TRA(2797) TFA(1054) P .value
MACE(%) 21(1.9)a,b 33(1.2)a 27(2.6)b 0.008*
Cardiac Death (%) 1(0.1)a,b 2(0.1)a 6(0.6)b 0.001*
Acute MI 20(1.8) 32(1.1) 22(2.1) 0.06
Stroke(%) 2 (0.2) 3 (0.1) 5(0.5) 0.07
Major access site Hematoma (%) 3(0.3)a 4(0.1)a 13(1.2)b 0.0001*
Aneurysm/Pseudo aneurysm (%) 8(0.7)a 1(0.01)b 5(0.5)a 0.001*
Procedure Success(%) 1080(98)a 2752(98.4)a 1008(95.6)b 0.0001*
Procedure time(min) 132.39 9.5 131.53  7.3 131.4  7.8 0.09
Fluoroscopy time (min) 21.1  14.5a 21.8 15.7a 34.7 26.9b 0.000*
Contrast Volume(mL) 111.9 60.1a 124 66.3 171 87.5 0.000x
Data are presented as mean+SD, or the number of patients/arteries (percentage);
TBA¼transbrachial approach; TRA¼transradial aaproach;TFA¼transfemoral approach; *The
same superscript letter denotes column proportions which do not differ signiﬁcantly from
each other at the .05 level,Different superscript letters means signiﬁcant difference between
its column proportions.Conclusions: Based on the previous data, transbrachial approach for PCI could be
a good alternative for the standard of care approaches with considerable safety and
efﬁcacy.JACC Vol 62/18/Suppl B j October 27–November 1, 2013 j TCT AbstrTCT-273
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Background: Use of bleeding avoidance strategies (BAS) such as transradial
access, bivalirudin, and femoral closure devices have been shown to lower bleeding
events after PCI but used most often in those at lowest risk of bleeding. Patient
characteristics that deter use of BAS in higher risk patients for bleeding are not clearly
established.
Methods: Patients undergoing PCI at four University of Pittsburgh Medical Center
afﬁliated hospitals were enrolled in a hospital-based registry and followed prospec-
tively beginning in October 2011. Bleeding events and bleeding risk score (BRS) were
deﬁned by NCDR criteria and deﬁnitions. Low risk of bleeding deﬁned as score<13
and high risk of bleeding as score13.
Results: Among 2178 consecutive PCI patients (66.7% for acute coronary syndrome),
978 patients had a calculated BRS of <13 and 1200 patients 13. BAS use more
likely in the low risk group (91.1 vs 83.0%, p¼0.0001). Speciﬁc strategy used in the
low and high-risk groups were femoral access closure only in 23.5 vs 28.2% (p¼0.01),
bivalirudin only in 21.6 vs 21.1% (p¼0.78), transradial access only in 4.1 vs 3.8%
(p¼0.68), and a combination of BAS in 41.9 vs 30% (p¼0.0001). Among the high
risk group, logistic regression was used to determine the independent risk factors
associated with use of BAS (Figure 1).Conclusions: Utilization of a BAS has been increasingly advocated for especially in
high-risk patients for bleeding. However, recognizing deterrents to utilization allows
for understanding if use is even feasible and further studies are necessary to study the
safety and efﬁcacy of BAS in higher risk patients.
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Background: Despite advances in interventional cardiology, and that safety and
feasibility of outpatient percutaneous coronary intervention (PCI) has been previously
demonstrated, overnight stay after PCI remains the standard of care in the United
States. The study aims to compare outcomes, patient satisfaction, and cost of same day
(SD) vs. delayed hospital discharge (DD) after PCI-stenting and femoral hemostasis
with a vascular closure device (StarClose or ProGlide).
Methods: Consecutive patients undergoing coronary angiography (n¼2,480) at
University of Southern California Hospitals were screened; 493 patients were con-
sented for inclusion. Four hours following PCI, 100 patients were randomized to SD
(n¼50) or DD (n¼50). Patients were followed for one month and patient satisfaction
surveys completed at 24 hours and one-month post discharge. Cost savings were
calculated based on Medicare payment rates.
Results: SD and DD groups were well distributed with similar baseline demographic
and angiographic characteristics. Mean age was 58.18.8, 86% were male, 16%
smokers, 44% diabetic, 41% had history of MI and 31% CRI. NSTEMI or
unstable angina (UA) was the presentation in 30% of SD vs. 44% of DD
patients (p¼0.2) and all other patients had stable angina (SA) (70% in DD vs. 56% in
SD, p¼0.15). Multivessel stenting was performed in 74% and 60% of SD and
DD groups, respectively (p¼0.14). At 30 days post-discharge, the primary end
point (death, myocardial infarction or repeat revascularization) occurred in one
DD patient (2%) vs. two SD patients (4%), p¼1.0. The secondary end points ofacts/POSTER/Vascular Access and Closure B89
